EUCAST technical note on Candida and micafungin, anidulafungin and fluconazole

Mycoses. 2014 Jun;57(6):377-9. doi: 10.1111/myc.12170. Epub 2014 Jan 13.

Abstract

The European Committee on Antimicrobial Susceptibility Testing Subcommittee on Antifungal Susceptibility Testing has determined breakpoints for micafungin and revised breakpoints for anidulafungin and fluconazole for Candida spp. This Technical Note is based on the corresponding rationale documents (http://www.eucast.org). The micafungin breakpoints are based on PK data, animal PK/PD data, microbiological data and clinical experience. The anidulafungin breakpoints for C. parapsilosis and fluconazole breakpoints for C. glabrata have been modified to species-specific values that categorise the wild-type as intermediate to accommodate use of these compounds in some clinical situations.

Keywords: Candida; EUCAST breakpoints; MIC; microdilution; susceptibility testing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anidulafungin
  • Animals
  • Antifungal Agents / pharmacokinetics
  • Antifungal Agents / pharmacology*
  • Candida / drug effects*
  • Echinocandins / pharmacokinetics
  • Echinocandins / pharmacology*
  • Europe
  • Fluconazole / pharmacokinetics
  • Fluconazole / pharmacology*
  • Humans
  • Lipopeptides / pharmacokinetics
  • Lipopeptides / pharmacology*
  • Micafungin
  • Microbial Sensitivity Tests / standards

Substances

  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • Fluconazole
  • Anidulafungin
  • Micafungin